Evaluation and management of the patient with pulmonary arterial hypertensionRUBIN, Lewis J; BADESCH, David B.Annals of internal medicine. 2005, Vol 143, Num 4, pp 282-292, issn 0003-4819, 11 p.Article

Pulmonary hypertension associated with connective tissue diseaseFAGAN, Karen A; BADESCH, David B.Progress in cardiovascular diseases. 2002, Vol 45, Num 3, pp 225-234, issn 0033-0620, 10 p.Article

Medical therapy for pulmonary arterial hypertension : Updated ACCP evidence-based clinical practice guidelinesBADESCH, David B; ABMAN, Steven H; SIMONNEAU, Gerald et al.Chest. 2007, Vol 131, Num 6, pp 1917-1928, issn 0012-3692, 12 p.Article

Metastatic cancer while receiving continuous prostacyclin therapyFAGAN, Karen A; BULL, Todd M; BADESCH, David B et al.Chest. 2005, Vol 128, Num 6, pp 619S-620S, issn 0012-3692, SUPConference Paper

Formulary Management of Recombinant Factor VIIa at an Academic Medical CenterOWEN, Phillip S; GOLIGHTLY, Larry K; MACLAREN, Robert et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 6, pp 771-776, issn 1060-0280, 6 p.Article

Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension: The SUPER-2 StudyRUBIN, Lewis J; BADESCH, David B; BARST, Robyn J et al.Chest (American College of Chest Physicians). 2011, Vol 140, Num 5, pp 1274-1283, issn 0012-3692, 10 p.Article

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL: Identifying Systemic Sclerosis as a Unique PhenotypeCHUNG, Lorinda; LIU, Juliana; PARSONS, Lori et al.Chest (American College of Chest Physicians). 2010, Vol 138, Num 6, pp 1383-1394, issn 0012-3692, 12 p.Article

End Points and Clinical Trial Design in Pulmonary Arterial HypertensionMCLAUGHLIN, Vallerie V; BADESCH, David B; PROVENCHER, Steeve et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 1, issn 0735-1097, S97-S107, SUPArticle

Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test AbnormalitiesMCGOON, Michael D; FROST, Adaani E; RUBIN, Lewis et al.Chest (American College of Chest Physicians). 2009, Vol 135, Num 1, pp 122-129, issn 0012-3692, 8 p.Article

Serotonin Transporter Polymorphisms in Patients With Portopulmonary HypertensionROBERTS, Kari E; FALLON, Michael B; HORN, Evelyn M et al.Chest (American College of Chest Physicians). 2009, Vol 135, Num 6, pp 1470-1475, issn 0012-3692, 6 p.Article

Diagnosis and Assessment of Pulmonary Arterial HypertensionBADESCH, David B; CHAMPION, Hunter C; TORBICKI, Adam et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 1, issn 0735-1097, S55-S66, SUPArticle

Bosentan therapy for pulmonary arterial hypertensionRUBIN, Lewis J; BADESCH, David B; LANDZBERG, Michael et al.The New England journal of medicine. 2002, Vol 346, Num 12, pp 896-903, issn 0028-4793Article

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. CommentaryDUPUIS, Jocelyn; CHANNICK, Richard N; BODIN, Frédéric et al.Lancet (British edition). 2001, Vol 358, Num 9288, pp 1113-1114, issn 0140-6736, 7 p.Article

An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell DiseaseKLINGS, Elizabeth S; MACHADO, Roberto F; ROSENZWEIG, Erika B et al.American journal of respiratory and critical care medicine. 2014, Vol 189, Num 6, pp 727-740, issn 1073-449X, 14 p.Article

Portopulmonary Hypertension: A Report From the US-Based REVEAL RegistryKROWKA, Michael J; MILLER, Dave P; BARST, Robyn J et al.Chest (American College of Chest Physicians). 2012, Vol 141, Num 4, pp 906-915, issn 0012-3692, 10 p.Article

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL RegistryBADESCH, David B; RASKOB, Gary E; GILES, Scott et al.Chest (American College of Chest Physicians). 2010, Vol 137, Num 2, pp 376-387, issn 0012-3692, 12 p.Article

Depressive Symptoms in Pulmonary Arterial Hypertension: Prevalence and Association With Functional StatusMCCOLLISTER, Deborah H; BEUTZ, Michelle; MCLAUGHLIN, Vallerie et al.Psychosomatics (Washington, DC). 2010, Vol 51, Num 4, issn 0033-3182, p. 339Article

Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous EpoprostenolBADESCH, David B; MCGOON, Michael D; BARST, Robin J et al.Journal of rheumatology. 2009, Vol 36, Num 10, pp 2244-2249, issn 0315-162X, 6 p.Article

Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized TrialSIMONNEAU, Gérald; RUBIN, Lewis J; COSSONS, Nandini et al.Annals of internal medicine. 2008, Vol 149, Num 8, pp 521-530, issn 0003-4819, 10 p.Article

Definitions and Diagnosis of Pulmonary HypertensionHOEPER, Marius M; BOGAARD, Harm Jan; WILKINS, Martin R et al.Journal of the American College of Cardiology. 2013, Vol 62, Num 25, issn 0735-1097, D42-D50, SUPDConference Paper

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL RegistryBENZA, Raymond L; MILLER, Dave P; BARST, Robyn J et al.Chest (American College of Chest Physicians). 2012, Vol 142, Num 2, pp 448-456, issn 0012-3692, 9 p.Article

Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United KingdomSACHDEV, Vandana; KATO, Gregory J; NOVELLI, Enrico M et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 13, pp 1452-1460, issn 0009-7322, 9 p.Article

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States: How REVEAL Differs From Historic and Non-US Contemporary RegistriesFROST, Adaani E; BADESCH, David B; FELDKIRCHER, Kathleen et al.Chest (American College of Chest Physicians). 2011, Vol 139, Num 1, pp 128-137, issn 0012-3692, 10 p.Article

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)BENZA, Raymond L; MILLER, Dave P; LIOU, Theodore G et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 2, pp 164-172, issn 0009-7322, 9 p.Article

Pulmonary hypertension in lung diseases: Survey of beliefs and practice patternsMINAI, Omar A; NATHAN, Steven D; HILL, Nicholas S et al.Respiratory medicine. 2010, Vol 104, Num 5, pp 741-748, issn 0954-6111, 8 p.Article